Gilead Sciences
Data Breaches, Cyber Attacks and Security Report

https://gilead.com  ᛫  Biotech & Pharmaceuticals
Last updated November 12, 2019

About Gilead Sciences

Company Overview

Gilead Sciences, Inc., commonly known as Gilead Sciences or Gilead (also styled GILEAD), is an American biotechnology company that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi. Headquartered and founded in Foster City, California, Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500.

Valuation

Employees

CEO

John Milligan

Location

Data Breaches and Security News

Gilead Sciences Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Gilead Sciences is implementing good security practices.

Passed Checks

Passed{{ passedCheck.passTitle }}

Failed Checks

Warning{{ failedCheck.failTitle }}

View a free security report for Gilead Sciences

Get full security report ›

Related posts

Read more about the latest issues in cybersecurity

More security reports

Compare Gilead Sciences's security performance with other companies